Renalytix Plc (RNLX)
NASDAQ: RNLX · IEX Real-Time Price · USD
0.293
-0.010 (-3.40%)
At close: Jul 19, 2024, 4:00 PM
0.301
+0.008 (2.77%)
Pre-market: Jul 22, 2024, 7:37 AM EDT
Renalytix Revenue
Renalytix had revenue of $2.22M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $535.00K. In the fiscal year ending June 30, 2023, Renalytix had annual revenue of $3.40M with 14.58% growth.
Revenue (ttm)
$2.22M
Revenue Growth
-40.23%
P/S Ratio
11.97
Revenue / Employee
$21,775
Employees
102
Market Cap
26.57M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 3.40M | 433.00K | 14.58% |
Jun 30, 2022 | 2.97M | 1.48M | 99.20% |
Jun 30, 2021 | 1.49M | - | - |
Jun 30, 2020 | 0 | - | - |
Jun 30, 2019 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRNLX News
- 11 days ago - Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US - GlobeNewsWire
- 24 days ago - Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination - GlobeNewsWire
- 5 weeks ago - Medicare Issues Final Coverage Determination for kidneyintelX.dkd - GlobeNewsWire
- 2 months ago - Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024 - GlobeNewsWire
- 2 months ago - Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15 - GlobeNewsWire
- 3 months ago - Renalytix Announces Financing with Expected Size of up to $4 Million - GlobeNewsWire
- 4 months ago - KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD) - GlobeNewsWire
- 5 months ago - Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024 - GlobeNewsWire